List view / Grid view
6 October 2015 | By Victoria White
Frost & Sullivan have found that non-therapeutic use of human albumin as an excipient has generated plenty of interest across the industry...
6 October 2015 | By Victoria White
Researchers have found that they can use gene therapy to improve visual in mice models for the vision disorder Leber hereditary optic neuropathy (LHON)...
5 October 2015 | By Victoria White
Initial studies by Oxford University researchers show that targeting the protein, called PAT4, could restrict cancerous cells' ability to grow...
5 October 2015 | By Victoria White
Rats given RGFP966 were more attuned to what they were hearing and were able to retain and remember more information...
5 October 2015 | By Victoria White
The Nobel Prize for Physiology or Medicine has been split this year to recognise work that has revolutionised the treatment of some parasitic diseases...
5 October 2015 | By Victoria White
Biogen will leverage findings from Genomics’ integrated database and analysis tools, which will be used to guide drug research and development...
2 October 2015 | By Victoria White
Elevated levels of TGFb may drive the progression of advanced metastatic cancer. As such, it has become an attractive target for cancer drug development...
2 October 2015 | By Victoria White
The technique allows drugs to last longer in the body and attack both primary cancer tumours and the circulating tumour cells...
2 October 2015 | By Victoria White
Genesphere's goal is to license the 3DNA platform to pharmaceutical partners and complete the preclinical work necessary to advance the its own lead drug candidates...
2 October 2015 | By Victoria White
Scientists have discovered a protein that 'soaks up' the overproduced hormone that leads to diabetic enteropathy...
2 October 2015 | By Victoria White
Understanding how genomic variants contribute to disease may help clinicians develop improved diagnostics and treatments, in addition to new methods of prevention...
1 October 2015 | By Victoria White
Scientists have uncovered a relationship between a chemical that helps transmit signals in the brain and genetic mutations present in a subset of individuals with autism...
1 October 2015 | By Victoria White
The TaNeDS programme provides close partnership between successful applicants and scientists in Daiichi Sankyo to tackle unmet medical needs...
1 October 2015 | By Victoria White
If further studies show this route can benefit patients, it could help crack one of the toughest challenges in cancer research – how to stop tumours spreading...
30 September 2015 | By Victoria White
BLU-554, an exquisitely selective inhibitor of fibroblast growth factor receptor 4 (FGFR4), is currently being evaluated in a Phase 1 clinical trial in patients with advanced hepatocellular carcinoma...
